31 July 2021>: Clinical Research
Clinical Benefit of Therapeutic Drug Monitoring in Colorectal Cancer Patients Who Received Fluorouracil-Based ChemotherapyXingqin Zhou 1BCE , Yazhou Chang 2BD , Jing Qian 1BF , Chaoyan Shen 1DEF , Jie Han 1EF , Hongyu Zhao 1DF , Renan Chang 3AG*
Med Sci Monit 2021; 27:e929474
Figure 4 Percentage of all kinds of therapeutic outcomes between the Study Group and the Historical Group. CR – complete response; PR – partial response; SD – stable disease; PD – progressive disease. * P<0.05 represents statistical difference.